Tech Company Inital Public Offerings
Pfenex IPO
Pfenex, operating out of San Diego, debuted as a public company on 7/24/2014.
Transaction Overview
Company Name
Announced On
7/24/2014
Transaction Type
IPO
Amount
$49,800,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10790 Roselle St.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Headquartered in San Diego, California, Pfenex Inc. (NYSE MKT: PFNX) is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jason Grenfell-Gardner
Chief Executive Officer
Eef Schimmelpennink
Chief Financial Officer
Susan Knudson
Chief Medical Officer
Hubert Chen
Vice President
Mayda Mercado
VP - Bus. Development
Patrick Lucy
Browse more venture capital transactions:
Prev: 7/24/2014: Fixed venture capital transaction
Next: 7/24/2014: QuarterSpot venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs